Take Your Trading To The Next Level. Get Started Here!
+1 (949) 514 8188
Casgevy uses Nobel Prize-winning technology CRISPR to treat sickle cell disease, a blood disorder that affects about 100,000 Americans.
U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease
Casgevy uses Nobel Prize-winning technology CRISPR to treat sickle cell disease, a blood disorder that affects about 100,000 Americans.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender